Human albumin and starch administration in critically ill patients: a prospective randomized clinical trial

Wiener klinische Wochenschrift
Thiemo F VenemanArend J J Woittiez

Abstract

To determine whether intravenous infusion of either human albumin or hydroxyethyl-starch (HES) in hypo-albuminemic critically ill may lead to an increase in colloid osmotic pressure and to a better clinical outcome, i.e. lower mortality and fewer complications, compared to fluid replacement with normal saline. Prospective, randomized controlled clinical trial during 72 hours in 61 consecutively admitted severely ill patients. Randomisation took place by sealed envelope, kept outside of the hospital. Intensive care unit of the Twenteborg Hospital, Almelo, The Netherlands. Sixty-three severely ill, hypo-albuminemic patients were selected; 27 patients had severe sepsis and 36 were post-surgical patients with SIRS. Two patients died shortly after randomization, 15 patients received human albumin, 15 HES 500 and 15 HES 1000 ml, and 16 saline. The patients were randomized to receive 300 ml human albumin (20%) per day, or 1000 ml normal saline per day, or 500 ml or 1000 ml HES per day, all for 72 hours. The primary outcome was plasma colloid osmotic pressure (COP). Secondary endpoints were fluid balance and the development of pulmonary edema. Administration of human albumin was effective in raising COP (P<0.001 on day 2 and day 3, com...Continue Reading

References

Jun 1, 1990·Archives of Surgery·E F FoleyP N Benotti
Jul 1, 1989·Critical Care Medicine·T E Emerson
May 1, 1993·Acta Anaesthesiologica Scandinavica·T TønnessenH Noddeland
Jan 1, 1994·Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy·B A PockajS A Rosenberg
Jun 1, 1997·Journal of Clinical Epidemiology·P Goldwasser, J Feldman
Dec 13, 1997·European Journal of Clinical Investigation·B GuidetG Offenstadt
Mar 21, 1998·Intensive Care Medicine·J BoldtG Hempelmann
May 20, 1998·Drugs·J S Roberts, S L Bratton
Jul 24, 1998·BMJ : British Medical Journal·UNKNOWN Cochrane Injuries Group Albumin Reviewers
Feb 6, 1999·Critical Care Medicine·D ErnestP M Dodek
Feb 6, 1999·Critical Care Medicine·P T ChoiD J Cook

❮ Previous
Next ❯

Citations

Aug 3, 2005·Der Chirurg; Zeitschrift für alle Gebiete der operativen Medizen·G MarxK Reinhart
Jan 11, 2011·Annals of Surgery·A B Johan GroeneveldMahlon M Wilkes
Sep 4, 2010·BMJ : British Medical Journal·Samuel AkechKathryn Maitland
Jul 9, 2004·Wiener klinische Wochenschrift·Johan Groeneveld
Jan 29, 2013·Best Practice & Research. Clinical Anaesthesiology·Pedro Leme SilvaMarcelo Gama de Abreu
Nov 3, 2015·The British Journal of Surgery·S H QureshiG J Murphy
Feb 7, 2015·Journal of Veterinary Emergency and Critical Care·Katja N AdamikNadine Regenscheit
Sep 1, 2007·Current Opinion in Critical Care·Sean M Bagshaw, Rinaldo Bellomo
Oct 1, 2010·The American Journal of Clinical Nutrition·Nikki BuijsPaul A M van Leeuwen
Jun 23, 2019·Journal of Veterinary Emergency and Critical Care·Gaby van Galen, Gayle Hallowell
Sep 12, 2012·Annals of Surgery·Peter GoslingMav Manji
Oct 5, 2021·Medizinische Klinik, Intensivmedizin und Notfallmedizin·Gunnar Schley, Carsten Willam
Feb 8, 2011·Journal of Clinical Anesthesia·Ksenija Mahkovic-Hergouth, Lidija Kompan

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.